MEDS
Price
$5.84
Change
+$0.18 (+3.18%)
Updated
May 16, 6:59 PM EST
PETS
Price
$4.59
Change
+$0.06 (+1.32%)
Updated
May 16, 6:59 PM EST
3 days until earnings call
Ad is loading...

MEDS vs PETS

Header iconMEDS vs PETS Comparison
Open Charts MEDS vs PETSBanner chart's image
TRxADE HEALTH
Price$5.84
Change+$0.18 (+3.18%)
Volume$2.81K
CapitalizationN/A
PetMed Express
Price$4.59
Change+$0.06 (+1.32%)
Volume$176.8K
CapitalizationN/A
View a ticker or compare two or three
MEDS vs PETS Comparison Chart

Loading...

MEDSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PETSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
MEDS vs. PETS commentary
May 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDS is a Hold and PETS is a Hold.

COMPARISON
Comparison
May 17, 2024
Stock price -- (MEDS: $5.62 vs. PETS: $4.59)
Brand notoriety: MEDS and PETS are both not notable
Both companies represent the Drugstore Chains industry
Current volume relative to the 65-day Moving Average: MEDS: 12% vs. PETS: 86%
Market capitalization -- MEDS: $12.34M vs. PETS: $99.18M
MEDS [@Drugstore Chains] is valued at $12.34M. PETS’s [@Drugstore Chains] market capitalization is $99.18M. The market cap for tickers in the [@Drugstore Chains] industry ranges from $18.71B to $0. The average market capitalization across the [@Drugstore Chains] industry is $3.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MEDS’s FA Score shows that 0 FA rating(s) are green whilePETS’s FA Score has 1 green FA rating(s).

  • MEDS’s FA Score: 0 green, 5 red.
  • PETS’s FA Score: 1 green, 4 red.
According to our system of comparison, PETS is a better buy in the long-term than MEDS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MEDS’s TA Score shows that 5 TA indicator(s) are bullish while PETS’s TA Score has 4 bullish TA indicator(s).

  • MEDS’s TA Score: 5 bullish, 3 bearish.
  • PETS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MEDS is a better buy in the short-term than PETS.

Price Growth

MEDS (@Drugstore Chains) experienced а -9.65% price change this week, while PETS (@Drugstore Chains) price change was +7.36% for the same time period.

The average weekly price growth across all stocks in the @Drugstore Chains industry was -1.41%. For the same industry, the average monthly price growth was +1.02%, and the average quarterly price growth was -0.19%.

Reported Earning Dates

MEDS is expected to report earnings on Jul 24, 2023.

PETS is expected to report earnings on Jul 22, 2024.

Industries' Descriptions

@Drugstore Chains (-1.41% weekly)

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

SUMMARIES
A.I.dvisor published
a Summary for MEDS with price predictions.
OPEN
A.I.dvisor published
a Summary for PETS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
PETS($99.2M) has a higher market cap than MEDS($12.3M). MEDS YTD gains are higher at: 48.813 vs. PETS (-39.220). MEDS has higher annual earnings (EBITDA): -2.68M vs. PETS (-5.12M). PETS has more cash in the bank: 53.5M vs. MEDS (34K). PETS has less debt than MEDS: PETS (1.84M) vs MEDS (6.48M). PETS has higher revenues than MEDS: PETS (271M) vs MEDS (10.5M).
MEDSPETSMEDS / PETS
Capitalization12.3M99.2M12%
EBITDA-2.68M-5.12M52%
Gain YTD48.813-39.220-124%
P/E RatioN/A1465.00-
Revenue10.5M271M4%
Total Cash34K53.5M0%
Total Debt6.48M1.84M353%
FUNDAMENTALS RATINGS
MEDS vs PETS: Fundamental Ratings
MEDS
PETS
OUTLOOK RATING
1..100
215
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9891
PRICE GROWTH RATING
1..100
3964
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
9550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PETS's Valuation (93) in the Drugstore Chains industry is in the same range as MEDS (98) in the null industry. This means that PETS’s stock grew similarly to MEDS’s over the last 12 months.

PETS's Profit vs Risk Rating (100) in the Drugstore Chains industry is in the same range as MEDS (100) in the null industry. This means that PETS’s stock grew similarly to MEDS’s over the last 12 months.

PETS's SMR Rating (91) in the Drugstore Chains industry is in the same range as MEDS (98) in the null industry. This means that PETS’s stock grew similarly to MEDS’s over the last 12 months.

MEDS's Price Growth Rating (39) in the null industry is in the same range as PETS (64) in the Drugstore Chains industry. This means that MEDS’s stock grew similarly to PETS’s over the last 12 months.

PETS's P/E Growth Rating (1) in the Drugstore Chains industry is significantly better than the same rating for MEDS (100) in the null industry. This means that PETS’s stock grew significantly faster than MEDS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MEDSPETS
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 21 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
MEDSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PETSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EKBYX13.28N/A
N/A
Allspring Diversified Cap Bldr Inst
FKUQX21.97-0.02
-0.09%
Franklin Utilities A
GCAEX7.46-0.02
-0.27%
Gabelli Equity Income A
GIDUX7.35-0.03
-0.41%
Goldman Sachs Intl Eq Div & Prem R6
NEQCX11.55-0.07
-0.60%
Neuberger Berman U.S. Equity Impact C

MEDS and

Correlation & Price change

A.I.dvisor tells us that MEDS and LFMD have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEDS and LFMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDS
1D Price
Change %
MEDS100%
-2.01%
LFMD - MEDS
22%
Poorly correlated
-7.10%
PETS - MEDS
7%
Poorly correlated
+1.43%
LFLY - MEDS
5%
Poorly correlated
+6.38%
SSY - MEDS
4%
Poorly correlated
-0.05%
YI - MEDS
4%
Poorly correlated
+3.08%
More

PETS and

Correlation & Price change

A.I.dvisor tells us that PETS and WBA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PETS and WBA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PETS
1D Price
Change %
PETS100%
+1.43%
WBA - PETS
27%
Poorly correlated
+2.52%
LFMD - PETS
22%
Poorly correlated
-7.10%
YI - PETS
19%
Poorly correlated
+3.08%
BIMI - PETS
7%
Poorly correlated
+4.55%
LFLY - PETS
6%
Poorly correlated
+6.38%
More